Rescue therapy with tacrolimus for a patient with severe ulcerative colitis refractory to combination leukocytapheresis and high-dose corticosteroid therapy

Internal Medicine

Volumn 46, Issue 11, 2007, Pages 717-720

  Nakase, Hiroshi ^a   Mikami, Sakae ^a   Matsuura, Minoru ^a   Ueno, Satoru ^a   Uza, Norimitsu ^a   Inoue, Satoko ^a   Kitamura, Hiroshi ^a   Kasahara, Katsuhiro ^a   Yoshino, Takuya ^a   Takeda, Yasuhiro ^a   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Leykocytapheresis; Tacrolimus; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; MESALAZINE; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CONTINUOUS INFUSION; DIARRHEA; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG PULSE THERAPY; GASTROINTESTINAL ENDOSCOPY; HEMATOCHEZIA; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LEUKAPHERESIS; MALE; RELAPSE; SYMPTOM; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; COLITIS, ULCERATIVE; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKAPHERESIS; MALE; SALVAGE THERAPY; TACROLIMUS;

EID: 34250200118     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6219     Document Type: Article

References (20)

1. The US Multicenter Fk506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331: 1110-1115, 1994.
2. Kino T, Hatanaka H, Miyata S, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot(Tokyo) 40: 1256-1265, 1987.
3. Lowry PW, Weaver AL, Tremaine WJ, Sandborn WJ. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae. Inflamm Bowel Dis 5: 239-245, 1999.
4. Fellermann K, Herrlinger KR, Witthoeft T, Homann N, Ludwig D, Stange EF. Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease. Transplant Proc 33: 2247-2248, 2001.
5. Ogata H, Matsui T, Nakamura M, et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 55: 1255-1262, 2006.
6. Naganuma M, Funakoshi S, Sakuraba A, et al. Granulocytapheresis is useful as an alternative therapy in patients with steroidrefractory or -dependent ulcerative colitis. Inflamm Bowel Dis 10: 251-257, 2004.
7. Lichtiger S, Present DH, Kombluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330: 1841-1845, 1994.
8. Carbonnel F, Boruchowicz A, Duclos B, et al. Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci 41: 2471-2476, 1996.
9. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol 94: 1587-1592, 1999.
10. Rowe FA, Walker JH, Karp LC, Vasiliauskas EA, Plevy SE, Targan SR. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. Am J Gastroenterol 95: 2000-2008, 2000.
11. Kombluth A, Present DH, Lichiger S, Hanauer S. Cyclosporin for severe ulcerative colitis: a user's guide. Am J Gastroenterol 92: 1424-1428, 1997.
12. Armstrong VW, Oellerich M. New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. Clin Biochem 34: 9-16, 2001.
13. Peters DH, Fitton A, Plosker GI, Faulds D. Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs 46: 746-794, 1993.
14. Vanrenterghem Y. Tacrolimus (FK506) in kidney transplantation. Transplant Proc 31: 3298-3299, 1999.
15. van Hoff JP. Christiaans MHL Use of tacrolimus in renal transplantation Transplant Proc. 30: 2171-2173, 1998.
16. Gummert JF, Ikonen T, Morris RE. Newer Immunosuppressive drugs: a review. J Am Soc Nephrol 10: 1366-1380, 1999.
17. Bierer BE. Biology of cyclosporine A and FK506. Prog Clin Biol Res 390: 203-223, 1994.
18. Baumgart DC, Pintoffl JP, Sturm A, Wiedenmann B, Dignass AU. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease - a long-term follow-up. Am J Gastroenterol 101: 1048-1056, 2006.
19. Hogenauer C, Wenzl HH, Hinterleitner TA, Petritsch W. Effect of oral tacrolimus (FK506) on steroid-refractory moderate/severe ulcerative colitis. Aliment Pharmacol Ther 18: 415-423, 2003.
20. Baurngart DC, Wiedenmann B, Dignass AU. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther 17: 1273-1281, 2003.